Vantage Point

Vantage Point: Payers—the "experts" in healthcare research

Vantage Point: Payers—the "experts" in healthcare research

Access to payers is about knowledge, about understanding what they do in their jobs

Vantage Point: Determining "fair market value"

Vantage Point: Determining "fair market value"

Should pharma formulate a super matrix to determine the FMV of research incentives?

Vantage Point: Marketing Support for Clinical Trials

Vantage Point: Marketing Support for Clinical Trials

Pharmaceutical companies must provide robust marketing support for their clinical trials

Vantage Point: Boosting Quality, Containing Costs

Vantage Point: Boosting Quality, Containing Costs

A new industry has emerged to provide analytics and predictive tools that support optimized care

Vantage Point: Observational Research

Vantage Point: Observational Research

Pharma can be in the moment with customers as they interact with our information or products

Vantage Point: Big Data

Vantage Point: Big Data

Big Data is coming and with it the danger of pharmaceutical marketers relying on it too heavily

Vantage Point: Ringing in the new market

Vantage Point: Ringing in the new market

In 2014, the "new healthcare marketing" will become more discontinuous from the old

Vantage Point: Putting secondary research first

Vantage Point: Putting secondary research first

As I pull out my crystal ball, I see a day where we WANT to use secondary research first

Vantage Point: The Next Generation of Drugs

Vantage Point: The Next Generation of Drugs

The next generation of drugs sees a number of market access challenges

Vantage Point: A Revolution in Research

Vantage Point: A Revolution in Research

A quiet revolution is underway in research to keep pace with changes in medical marketing

Email Newsletters

MM&M inVISION